Atlas Trials

Stage IA Pancreatic Cancer

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IA Pancreatic Cancer

RecordFirmDate
VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer (NCT03373188)Emory University2017-12-15
Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study (NCT02345460)Case Comprehensive Cancer Center2015-09-01
Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery (NCT02511821)City of Hope Medical Center2015-07-22
Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection (NCT02506842)Fudan University2015-06-01
Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer (NCT02349867)Virginia Commonwealth University2015-01-29
Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer (NCT01918644)University of Wisconsin, Madison2014-04-08
Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery (NCT01954732)Case Comprehensive Cancer Center2014-01-01
Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy (NCT02414100)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2013-12-12
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer (NCT01959672)University of Nebraska2013-09-06
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery (NCT01234935)Translational Oncology Research International2011-01-13
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer (NCT01192763)National Cancer Institute (NCI)2010-08-01
Perioperative Therapy for Resectable Pancreatic Cancer (NCT00609336)University of Washington2008-01-01
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery (NCT00482625)National Cancer Institute (NCI)2007-06-01
Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery (NCT00305877)National Cancer Institute (NCI)2006-02-01

Track Stage IA Pancreatic Cancer automatically

Every clearance here is in the API, with alerts when new ones post.